RELIGARENSEReligare Enterprises Limited· FinanceLowNeutral
Announced Mon, 18 May · 22:10 IST

Religare Enterprises Limited has informed the Exchange about Transcript

Promoter Disclosed Acquisition PlansMgmt Guided Margin ImprovementMgmt Guided Margin PressureInvestor Communications View source PDF

RELIGARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.6%1-day move
₹219.30
prior close
₹220.74
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.0+0.6+1.8+3.6+5.0+9.9+7.6+10.8+8.3+4.4+15.5+17.6
Up moveDown movePending
AI summary

Religare Enterprises held its Q4 and FY26 earnings call discussing operational and financial performance. For FY26, the company reported total consolidated income of INR8,493 crores with PAT of INR73.16 crores. Care Health Insurance delivered strong performance with GWP of INR11,417 crores and PBT of INR539 crores (n basis), crossing the INR10,000 crores top-line milestone. Religare Finvest reported PAT of INR139 crores for FY26 with a cash balance of over INR591 crores. Religare Broking reported income of INR373 crores with PAT of INR22 crores, while Housing Finance reported a loss of INR18.6 crores. The company announced a demerger scheme to separate financial services (RFL) from health insurance (REL/Care), creating two focused listed entities. Promoter Burman Group increased stake to approximately 30.3% and remains committed to the business.

Likely market impact

The demerger announcement and strong Care Health performance are positive, but persistent losses in housing finance and ongoing shareholder concerns about holding company discount may weigh on investor sentiment. The company is in a rebuilding phase with new leadership across all subsidiaries.